Skip to main content
Fig. 2 | Trials

Fig. 2

From: Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial

Fig. 2

Intervention and assessment schedule for the GAZAI (GAZyvaro and response Adapted Involved-site Radiotherapy) trial. Abbreviations: AE adverse event, aPTT activated partial thromboplastin time, CR complete response, CT computed tomography, CTCAE Common Terminology Criteria for Adverse Events, ECOG Eastern Cooperative Oncology Group, EORTC European Organization for Research and Treatment of Cancer, FACT Lym Functional Assessment of Cancer Therapy - Lymphoma, FDG-PET/CT fludeoxyglucose positron emission tomography/computed tomography, INR international normalized ratio, IS involved site, LDH lactate dehydrogenase, MRD minimal residual disease, MRI magnetic resonance imaging, PTT partial thromboplastin time, QLQ Quality of Life Questionnaire, RT radiotherapy

Back to article page

Trials

ISSN: 1745-6215